Product
Supplier
Encyclopedia
Inquiry
Home > News > Paint & Coating News > Mitsubishi Chemical in Final Talks to Sell Pharmaceutical Unit to Bain Capital for $3.2 Billion

Mitsubishi Chemical in Final Talks to Sell Pharmaceutical Unit to Bain Capital for $3.2 Billion

ECHEMI 2025-01-22

Investment firm Bain Capital is in talks to acquire Mitsubishi Tanabe Pharma, a unit of Japan's Mitsubishi Chemical Group, in a potential deal, according to people familiar with the matter.

 

The two companies are in the final stages of negotiations and the deal could be worth more than 500 billion yen, or about $3.2 billion.

 

Earlier, Nikkei reported that Mitsubishi Chemical had granted a U.S. investment fund the right of first refusal to acquire its pharmaceutical unit.

 

Meanwhile, Mitsubishi Chemical said in response to the Nikkei report that it had no announcement to make.

 

"We are constantly reviewing the ideal mix of all businesses across the group, including pharmaceuticals, and are considering all options, including divestitures, to drive reform," the company said in a statement.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.

Looking for chemical products? Let suppliers reach out to you!

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.